Tezepelumab Significantly Reduces Nasal Polyp Severity and the Need for Surgery
Fifty-two weeks of Tezepelumab significantly reduces nasal polyps in adults with chronic rhinosinusitis according to new research being...
Read disclosure →Corporate Disclosures & Press Wire (5)
Labeling of Animal-Free Medications Needed for Patients with Alpha-Gal Syndrome
An 81.9% increase in animal-free medication inquiries highlights an emerging need for patients with alpha-gal syndrome according to new...
Read disclosure →
EDS-FLU Reduces Symptoms of Chronic Rhinosinusitis Regardless of Nasal Polyps
An exhalation delivery system with fluticasone (EDS-FLU) may reduce symptoms of chronic rhinosinusitis and improve patient's quality of...
Read disclosure →
No Evidence of Adverse Pregnancy Outcomes in Women Treated with Allergen-specific Immunotherapy Early in Pregnancy
A new study showed no evidence that women experienced adverse events in their pregnancies if they had been treated with allergen-specific...
Read disclosure →
Allergic Reactions to COVID Vaccines Rare and Do Not Preclude Immunization
While individuals with a history of severe allergy are at higher risk for a reaction to the COVID-19 vaccine, those reactions are rare...
Read disclosure →